TaqMan™ hPSC Scorecard™ Kit, Fast 96-well
TaqMan™ hPSC Scorecard™ Kit, Fast 96-well
Applied Biosystems™

TaqMan™ hPSC Scorecard™ Kit, Fast 96-well

Applied Biosystems™ TaqMan™ hPSC Scorecard™キット2 x 96w FASTは、ES細胞およびiPS細胞株の両方で、多能性の検証と系統バイアスの測定を可能にします詳細を見る
製品番号(カタログ番号)数量
A158712 x 96-well plates
製品番号(カタログ番号) A15871
価格(JPY)
141,800
Each
お問い合わせください ›
数量:
2 x 96-well plates
Applied Biosystems™ TaqMan™ hPSC Scorecard™キット2 x 96w FASTは、ES細胞およびiPS細胞株の両方で、多能性の検証と系統バイアスの測定を可能にします。2つの96ウェルプレートそれぞれには、ウェル内に乾燥させた94の定義済みTaqMan™遺伝子発現アッセイ(内在性コントロールを含む)が含まれています。便利なマスターミックスが付属しています。パネルのみを購入される場合は、TaqMan hPSC Scorecard™パネル2 x 96W FAST™を参照してください。この製品は384ウェルフォーマットでもご利用いただけます。

•1回のシンプルな実験で全遺伝子シグネチャーを評価
• 付属のhPSC Scorecard™ 分析ソフトウェアで、標準品と結果を比較
• 三杯葉分化能を持つ株を特定
• 一胚葉に指定された誘導分化を評価
• 検証済みコンテンツにアクセスして結果の信頼性を向上

1回の実験で全遺伝子シグネチャーを評価
TaqMan™ hPSC Scorecard™ パネルは、安定した便利な乾燥フォーマットでプレプレーティングアッセイを提供することで、時間の節約に役立ちます。目的のcDNAにTaqMan™ マスターミックスを添加し、マルチチャンネルピペットで96ウェルプレートに転写するだけです。

結果を標準品と比較
TaqMan™ hPSC Scorecard™ パネルには、独自のクラウドベースの解析ソフトウェアへのアクセスが含まれており、グラフや表の結果の表示およびエクスポート、ならびにレポートの生成が可能です。このソフトウェアは 7つのApplied Biosystems™ qRT-PCRシステムに対応しており、追加料金なしでご利用いただけます。

三胚葉分化能を持つ株の同定
分析には、ランダムに分化した胚様体(EB)サンプル(標準的なEB法を使用して少なくとも7日間分化)が含まれ、株が三胚葉(内胚葉、中胚葉、外胚葉)のうちの1つまたは複数に偏りがあるかどうかを判断します。

一胚葉に指定された誘導分化を評価
パネルには、三胚葉それぞれに20を超えるマーカーが含まれており、単層培養で方向づけられた分化に期待どおりに反応することが示されているいます。この1つのパネルで、目的の生殖層の時間経過データ、培養条件、および培地組成を迅速に評価できます。

アクセス検証済みコンテンツ
パネルのFAST内容は公開された作業(Bock et al., Cell 144, 439–452, 2011)に基づいており、複数のヒトESおよびiPSの線に対して検証されています。

得られる結果
TaqMan™ hPSC Scorecard™パネル2 x96w FASTのコンポーネント:

•94 TaqMan™遺伝子発現アッセイの96ウェルプレート2個
• 2つの光学プレートカバー
• 2本の1 mLバイアルTaqMan™ Fast Advancedマスターミックス
研究用にのみ使用できます。診断用には使用いただけません。
仕様
使用対象 (装置)QuantStudio™ 12k Flex、StepOnePlus™、高速モード、ViiA™ 7システム
フォーマット96-ウェルプレート
反応数96反応
製品ラインTaqMan
数量2 x 96-well plates
研究カテゴリー幹細胞研究
ヒト
検出法プライマープローブ検出
使用対象(アプリケーション)Stem Cell Analysis
形状乾燥
反応速度高速
Unit SizeEach
組成および保存条件
• 2つの96ウェルプレート、それぞれに96アッセイパネル(室温)が含まれます
• 2つの光学カバー(室温)
• TaqMan™ Fast Advancedマスターミックス、1 mLバイアル2本(解凍して輸送、再凍結しないこと、2~8℃で保管

よくあるご質問(FAQ)

Will I need to update my TaqMan hPSC Scorecard Analysis Software?

No software update is required. Because the hPSC Scorecard Analysis Software is cloud based, you will always have access to the most up-to-date version of the software every time you log in.

Find additional tips, troubleshooting help, and resources within our Real-Time PCR and Digital PCR Applications Support Center

How do I export Ct values in the TaqMan hPSC Scorecard Analysis Software?

The only way to view the Ct values in the current version is through the expression plot. We expect the software's Excel export to include the gene names and Ct values in a future version of the software.

Find additional tips, troubleshooting help, and resources within our Real-Time PCR and Digital PCR Applications Support Center

I'm using the TaqMan hPSC Scorecard Analysis Software. How are the scores calculated?

A proprietary algorithm compares the Ct values for each marker set to the values in the reference database and calculates the score based on how well the expression correlates. In general, scores close to 0 indicate comparable expression to that of the reference standard using undifferentiated cells. Scores higher than 1 indicates up regulation relative to undifferentiated cells and less than -1 indicate down regulation relative to undifferentiated cells.

Find additional tips, troubleshooting help, and resources within our Real-Time PCR and Digital PCR Applications Support Center

I'm using the TaqMan hPSC Scorecard Analysis Software. What lines were used to generate the reference standard?

Thirteen pluripotent stem cell lines were used to generate the reference standard including:

  • H9 ESC P28
  • iPS BS3C P35
  • iPS18C P29
  • HUES9 P28
  • HUES13 P56
  • HUES28 P28
  • HUES44 P25
  • HUES48 P21
  • HUES49 P21
  • HUES53 P24
  • HUES63 P46
  • HUES64 P30
  • HUES65 P29


Find additional tips, troubleshooting help, and resources within our Real-Time PCR and Digital PCR Applications Support Center

I'm using the TaqMan hPSC Scorecard Analysis Software. My sample has a red flag on it, or is not showing any results. What does that mean?

The hPSC Scorecard Analysis Software performs a set of quality control checks upon data import to ensure the quality of the results.
You may see one of the following red flag warnings:

  • Internal positive control: The expression levels of the housekeeping genes were low, signifying that there was an issue with the qRT-PCR. The sample is excluded from analysis and must be repeated.
  • Bad Rox: The ROX dye is used as a passive reference during the qPCR. If the ROX dye is not detected, it is suggestive that some of the assay wells may not have received the proper amount of Master Mix. This may explain why a particular assay is not showing the anticipated gene expression level.
  • Sendai Virus Detected (SEV): The hPSC Scorecard Panel includes a control to look for Sendai virus expression. A flag will appear if a Ct value of greater than 30 is observed for this control. On some rare occasions, the SEV oligonucleotides will cross react with other genes resulting in a false SEV flag in differentiated cells. If you see this flag, and did not anticipate Sendai virus detection, you may want to repeat the sample or look at the amplification plot (In the 96 well plate: well B9; in the 384 well plate: wells D3, D9, D15, and D21) to see if the automated Ct value call is real, or just an error.
  • Insufficient Data: The analysis software requires a minimum number of genes to be amplified in each the four categories (i.e., self-renewal (“pluri”), ectoderm, mesoderm, and endoderm) to accurately analyze your data. If the minimum number of genes in each category does not amplify, or if data has been omitted by the user, the Insufficient Data flag will appear and the sample is excluded from analysis. The sample should be repeated.


Find additional tips, troubleshooting help, and resources within our Real-Time PCR and Digital PCR Applications Support Center

引用および参考文献 (20)

引用および参考文献
Abstract
Characterizing Pluripotent Stem Cells Using the TaqMan(®) hPSC Scorecard (TM) Panel.
Authors:Fergus J, Quintanilla R, Lakshmipathy U,
Journal:
PubMed ID:25138722
'Rapid technological developments for the efficient generation of footprint-free induced pluripotent stem cells (iPSC) enabled the creation of patient-specific iPSC for downstream applications in drug discovery and regenerative medicine. However, the large number of iPSCs, generated from diverse genetic backgrounds using various methods and culture conditions, created a steep challenge ... More
Generation of iPSCs as a Pooled Culture Using Magnetic Activated Cell Sorting of Newly Reprogrammed Cells.
Authors:Yang W, Liu Y, Slovik KJ, Wu JC, Duncan SA, Rader DJ, Morrisey EE,
Journal:
PubMed ID:26281015
'Although significant advancement has been made in the induced pluripotent stem cell (iPSC) field, current methods for iPSC derivation are labor intensive and costly. These methods involve manual selection, expansion, and characterization of multiple clones for each reprogrammed cell sample and therefore significantly hampers the feasibility of studies where a ... More
Efficient Generation of Induced Pluripotent Stem and Neural Progenitor Cells From Acutely Harvested Dura Mater Obtained During Ventriculoperitoneal Shunt Surgery.
Authors:Cary WA, Hori CN, Pham MT, Nacey CA, McGee JL, Hamou M, Berman RF, Bauer G, Nolta JA, Waldau B,
Journal:
PubMed ID:26074438
'The dura mater can be easily biopsied during most cranial neurosurgical operations. We describe a protocol that allows for robust generation of induced pluripotent stem cells (iPSCs) and neural progenitors from acutely harvested dura mater. To generate iPSCs and neural progenitor cells from dura mater obtained during ventriculoperitoneal shunt surgery. ... More
Integrative Analyses of Human Reprogramming Reveal Dynamic Nature of Induced Pluripotency.
Authors:Cacchiarelli D, Trapnell C, Ziller MJ, Soumillon M, Cesana M, Karnik R, Donaghey J, Smith ZD, Ratanasirintrawoot S, Zhang X, Ho Sui SJ, Wu Z, Akopian V, Gifford CA, Doench J, Rinn JL, Daley GQ, Meissner A, Lander ES, Mikkelsen TS,
Journal:
PubMed ID:26186193
'Induced pluripotency is a promising avenue for disease modeling and therapy, but the molecular principles underlying this process, particularly in human cells, remain poorly understood due to donor-to-donor variability and intercellular heterogeneity. Here, we constructed and characterized a clonal, inducible human reprogramming system that provides a reliable source of cells ... More
Transcription factor binding dynamics during human ES cell differentiation.
Authors:Tsankov AM, Gu H, Akopian V, Ziller MJ, Donaghey J, Amit I, Gnirke A, Meissner A,
Journal:
PubMed ID:25693565
'Pluripotent stem cells provide a powerful system to dissect the underlying molecular dynamics that regulate cell fate changes during mammalian development. Here we report the integrative analysis of genome-wide binding data for 38 transcription factors with extensive epigenome and transcriptional data across the differentiation of human embryonic stem cells to ... More